跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Isovaleric Acid
首页
药物
Isovaleric Acid
Experimental
Small Molecule
Isovaleric Acid
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
5
H
10
O
2
CAS 编号
503-74-2
UNII ID
1BR7X184L5
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Deodorant material
US 8691201 B2
申请人: TANAKA TOSHIHIRO
优先权: 2008
CN
EP
US
WO
5 件公开
BREAST MILK OLIGOSACCHARIDE FOR IMPROVING INTESTINAL MICROENVIRONMENT HEALTH AND USE THEREOF
EP 4252538 A4
申请人: INNER MONGOLIA YILI IND GROUP
优先权: 2020
CN
EP
US
WO
5 件公开
NOVEL B0AT1 INHIBITOR
EP 4470533 A4
申请人: TANABE PHARMA CORP
优先权: 2022
CN
EP
US
WO
4 件公开
US 20260001849 A1
申请人: MITSUBISHI TANABE PHARMA CORP
优先权: 2023
EP
US
WO
3 件公开
A VETERINARY COMPOSITION FOR THE TREATMENT AND/OR PREVENTION OF PROTOZOAN DISEASES IN ANIMALS, COMPRISING AN ESSENTIAL OIL AND METHOD OF PREPARATION THEREOF
EP 4178587 A1
申请人: ADIFEED SP Z O O
优先权: 2020
EP
US
WO
3 件公开
EP 4178561 A1
申请人: ADIFEED SP Z O O
优先权: 2020
EP
WO
2 件公开
Olfactory receptor for isovaleric acid and related malodorants and use thereof in assays for identification of blockers of malodor
US 7344845 B2
申请人: SENOMYX INC
优先权: 2002
US
3 件公开
<SMALLCAPS/>? ? ?GLAUCIUM? ? ? ? ?A VETERINARY COMPOSITION CONTAINING AS AN ACTIVE SUBSTANCE EITHER GLAUCINE OR AN EXTRACT FROM A HERB OF THESP., A METHOD OF MANUFACTURING THEREOF, AND ITS USE FOR THE PREVENTION AND/OR TREATMENT OF DISEASES CAUSED BY PROTOZOA OF <NS1:I>APICOMPLEXA</NS1:I>?PHYLUM IN ANIMALS
EP 4178600 A1
申请人: ADIFEED SP Z O O
优先权: 2020
EP
WO
2 件公开
USE OF ISOVALERIC ACID AND PRODRUG THEREOF IN PREPARATION OF DRUG FOR TREATING TUMORS
WO 2025218820 A1
申请人: THE FIRST AFFILIATED HOSPITAL ZHEJIANG UNIV SCHOOL OF MEDICINE ZHEJIANG PROVINCIAL FIRST HOSPITAL
优先权: 2024
CN
WO
2 件公开
Treating a variety of pathological conditions, including spasticity and convulsions, by effecting a modulation of CNS activity with isovaleramide, isovaleric acid, or a related compound
US 7265155 B2
申请人: NBS PHARMACEUTICALS INC
优先权: 2003
US
2 件公开
Natural ligand of G protein coupled receptor RCC356 and uses thereof
US 8008023 B2
申请人: CHEMCOM SA
优先权: 2008
US
2 件公开
Sustained-release formulations for treating CNS-mediated disorders
US 7235258 B1
申请人: NPS PHARMA INC
优先权: 2000
US
第 1 / 4 页
上一页
下一页
药物
反馈